| answer text |
<p>Medicines Pharmacy and Industry Group (MPIG) is part of the Department’s Innovation,
Growth and Technology Directorate, and leads policy for the Department on pharmaceuticals,
the medicines supply chain, and the role of pharmacies (including prescription charges).
MPIG is responsible for:</p><p> </p><p> </p><p> </p><p>- the delivery of the medicines
pricing schemes including the Pharmaceutical Price Regulation Scheme;</p><p> </p><p>-
the delivery of frameworks for medicines procurement in secondary care;</p><p> </p><p>-
sponsorship role for two of the Department’s arm’s length bodies;</p><p> </p><p>-
the National Institute for Health and Care Excellence; and</p><p> </p><p>- the Medicines
and Healthcare products Regulatory Agency.</p><p> </p><p> </p><p> </p><p>The key objective
of MPIG is to support the safe, efficient and effective access to and use of medicines
in the National Health Service.</p><p> </p><p> </p><p> </p><p>The delivery of MPIG
against plan is assessed internally through the Department’s Quarterly Corporate Accountability
Review system. The overall financial position and performance of the Department is
published in the Departmental Annual Report.</p><p> </p><p> </p><p> </p><p>In addition
the Department publishes, on a quarterly basis, the quarterly net payments and sales
information relating to the Pharmaceutical Price Regulation Scheme at:</p><p> </p><p>
</p><p> </p><p><a href="https://www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information"
target="_blank">https://www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</a></p><p>
</p>
|
|
